# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-284258
Filing Date
2024-12-23
Accepted
2024-12-23 16:49:11
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | d698846d424b5.htm | 424B5 | 405781
2 | GRAPHIC | g698846g01k22.jpg | GRAPHIC | 85761
3 | GRAPHIC | g698846g01p01.jpg | GRAPHIC | 59263
4 | GRAPHIC | g698846g06a06.jpg | GRAPHIC | 198564
5 | GRAPHIC | g698846g07g07.jpg | GRAPHIC | 213184
6 | GRAPHIC | g698846g08a08.jpg | GRAPHIC | 190983
7 | GRAPHIC | g698846g08m08.jpg | GRAPHIC | 204455
8 | GRAPHIC | g698846g12p12.jpg | GRAPHIC | 51060
| Complete submission text file | 0001193125-24-284258.txt |  | 1770862

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273984 | Film No.: 241574518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)